@SteveRoth not true. everyone involved in running blackrock is levered to high prices of incumbent assets. huge negative externality.

how do they do anything about the pharma company? whether via the pharma company or via someone else, they probably get some research published that suggests dangerous side effects, sadly but soberly encourage legislators and regulators to turn these drugs into the next fen-phen en.wikipedia.org/wiki/Fenflura